Provider review
Immortals review
A microdose you can choose at intake, at the same price as not choosing it.
Microdose is a dosage type inside one product, and the only published term is a quarter paid up front.
Price as published
Compounded semaglutide with glycine and B12 from $196/mo, billed quarterly with a three-month commitment paid up front · "Microdose" is a selectable dosage type at that same from-price · no membership fee
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The verdict
Immortals carries the clearest longevity framing on this board — GLP-1s presented as a metabolic intervention rather than a weight-loss one, which is the frame most people who microdose actually arrive in — and it backs that with unlimited physician follow-up, no membership fee, and a stated HSA/FSA path. "Microdose" is offered openly as a dosage type at intake rather than being something you have to talk a clinician into. The structural problem is that choosing it changes nothing about the bill: it is the same product at the same from-price, so a fraction of the drug costs what a personalised full dose does. And the only term published is a quarterly one, three months paid up front, so the smallest way to try it is a season rather than a month.
The trade-off we would want you to read first
⚠ Choosing the microdose does not lower the price — it is a dosage type inside the same product at the same from-price, so a fraction of the drug costs what a personalised full dose does
Who it suits, and who it does not
A good fit if
- You want a longevity frame rather than a weight-loss one around the same molecule
- You want to select a microdose at intake without negotiating for it
- You value unlimited physician follow-up and no membership fee more than a lower headline
- You are content to commit a quarter at a time
Look elsewhere if
- You expect the low dose to cost less — here it is the same product at the same price
- You want to pay month to month, or to leave after a month
- You want tirzepatide, or any needle-free route
- You want the dispensing pharmacy named
How the programme works
Bryan Johnson's longevity telehealth arm, selling compounded semaglutide bundled with glycine and B12 and framing GLP-1s as a longevity intervention rather than a weight-loss one — which is the frame most microdosers actually arrive in. Physicians are licensed in your state, follow-up messaging is unlimited for up to twelve months, there is no membership fee, and intake-to-door runs three to seven days. For a low-dose reader the structural problem is plain: "Microdose" is offered as a dosage type inside the same product at the same from-price, so choosing to take less does not reduce what you pay, and there is no monthly option to leave from.
At a glance
- Pricing structure
- Flat at every dose
- Consult
- Included in the price
- Compounding
- Not publicly identified
- Labs
- Not required
- Dietitian support
- Not included
Strengths
- Frames GLP-1s explicitly as longevity medicine rather than maximum weight loss, which is the frame a microdose reader is usually in
- "Microdose" is an openly offered dosage type at intake, not something you have to negotiate into a standard plan
- No membership fee stacked on the medication, and the program is stated as HSA/FSA reimbursable
- Unlimited follow-up messaging with licensed physicians for up to twelve months, included
- Semaglutide bundled with glycine and B12 in a single weekly injection, with intake-to-door quoted at three to seven days
The other trade-offs
- Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
- ⚠ There is no month-to-month option: the published rate is billed quarterly with three months paid up front, so the smallest commitment is a quarter
- Semaglutide only in the GLP-1 line we could price, and injectable only — no tirzepatide microdose and no needle-free route
- The dispensing pharmacies are described only as licensed U.S. pharmacies and are never named
Before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomised trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
Where this sits on the board
Immortals is one of 32 low-dose GLP-1 providers we track. The board lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Funding & disclosures
- A number of links are affiliate or referral links.
- Begin treatment through one and we may earn a commission via the Katalys network — at no added cost to you.
- What we write about a provider is the same either way — unflattering findings about one that pays us stay in.
- Full detail: disclosure page.